Industry: Drug discovery, diagnostics, biomarker profiling
Jinfiniti Biosciences is a biomedical research company specializing in high-throughput platforms to isolate RNA/DNA samples at high speed and affordable cost. The RNA/DNA samples are fundamental to basic and clinical research, representing a significant market for research institutions and the pharmaceutical industry.
Along with nucleic acid (RNA/DNA) isolation, Jinfiniti provides pharmaceutical companies and biomedical research enterprises with monoclonal antibodies, immune assays, small compounds, HTS drug screening and data management and analysis.
The company is also using its proprietary technology — the automated high-throughput platform — to discover novel biomarkers and therapies for diabetes and cancer. The potential revenue for these discoveries may reach billions of dollars.
Company website: Jinfiniti Biosciences